DR. JOSEPH MICHAEL PALUMBO
Psychiatric at Brookside Ave, Wayne, PA
License number
Pennsylvania MD-057541-L
Category
Psychiatric
Type
Psychiatry
Address
Address
616 Brookside Ave, Wayne, PA 19087
Phone
(610) 975-9165
(610) 975-9182 (Fax)
(610) 975-9182 (Fax)
Personal information
See more information about JOSEPH MICHAEL PALUMBO at radaris.comName
Address
Phone
314 Princeton Dr, Pittsburgh, PA 15235
330 Jefferson Ave, Bristol, PA 19007
4612 S Clearview Dr, Camp Hill, PA 17011
4308 Blakiston St, Philadelphia, PA 19136
616 Brookside Ave, Wayne, PA 19087
Professional information
Dr. Joseph M Palumbo, Wayne PA - MD (Doctor of Medicine)
Specialties:
Addiction Psychiatry
Address:
616 Brookside Ave, Wayne 19087
Certifications:
Addiction Psychiatry, 1994, Psychiatry, 1992
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
George Washington University / School of Medicine And Health Sciences
Yale U Sch Med-Norwalk Hosp
Yale University School Of Medicine
George Washington University / School of Medicine And Health Sciences
Yale U Sch Med-Norwalk Hosp
Yale University School Of Medicine
Treatment Of Sleep-Wake Disorders
US Patent:
2013013, May 30, 2013
Filed:
Jan 23, 2013
Appl. No.:
13/747508
Inventors:
SK Biopharmaceuticals Co., Ltd. - Seoul, KR
Wilhelmus H.I.M. Drinkenburg - Molenschot, NL
Joseph Palumbo - Saint Davids PA, US
Jonathan Sporn - Princeton NJ, US
Wilhelmus H.I.M. Drinkenburg - Molenschot, NL
Joseph Palumbo - Saint Davids PA, US
Jonathan Sporn - Princeton NJ, US
Assignee:
SK Biopharmaceuticals Co., Ltd. - Seoul
International Classification:
A61K 31/27
US Classification:
514489
Abstract:
This invention is directed to a method of treating Excessive daytime Sleepiness (EDS) in a subject, comprising the step of administering a therapeutically effective amount of a compound of Formula (I): Formula (I) or a pharmaceutically acceptable salt or ester thereof wherein Rx is a member selected from the group consisting of hydrogen, lower alkyl of 1 to 8 carbon atoms, halogen selected from F, Cl, Br and I, alkoxy containing 1 to 3 carbon atoms, nitro, hydroxy, trifluoromethyl, and thioalkoxy containing 1 to 3 carbon atoms; x is an integer of 1 to 3, with the proviso that R may be the same or different when x is 2 or 3; Rand Rcan be the same or different from each other and are independently selected from the group consisting of hydrogen, lower alkyl of 1 to 8 carbon atoms, aryl, arylalkyl, cycloalkyl of 3 to 7 carbon atoms; Rand Rcan be joined to form a 5 to 7-membered heterocycle substituted with a member selected from the group consisting of hydrogen, alkyl, and aryl groups, wherein the cyclic compound can comprise 1 to 2 nitrogen atoms and 0 to 1 oxygen atom, wherein the nitrogen atoms are not directly connected with each other or with the oxygen atom.
Treatment Of Sleep-Wake Disorders
US Patent:
8440715, May 14, 2013
Filed:
Jun 7, 2006
Appl. No.:
11/921995
Inventors:
Abdallah Ahnaou - Berchem, BE
Wilhelmus H. L. M. Drinkenburg - Molenschot, NL
Joseph Palumbo - Saint Davids PA, US
Jonathan Sporn - Princeton NJ, US
Wilhelmus H. L. M. Drinkenburg - Molenschot, NL
Joseph Palumbo - Saint Davids PA, US
Jonathan Sporn - Princeton NJ, US
Assignee:
SK Biopharmaceuticals Co., Ltd. - Seoul
International Classification:
A01N 47/10, A01N 33/02, A01N 33/18, A01N 33/24, A61K 31/27, A61K 31/135, A61K 31/04
US Classification:
514478, 514646, 514741
Abstract:
This invention is directed to a method of treating Excessive daytime Sleepiness (EDS) in a subject, comprising the step of administering a therapeutically effective amount of a compound of Formula (I): Formula (I) or a pharmaceutically acceptable salt or ester thereof wherein Rx is a member selected from the group consisting of hydrogen, lower alkyl of 1 to 8 carbon atoms, halogen selected from F, Cl, Br and I, alkoxy containing 1 to 3 carbon atoms, nitro, hydroxy, trifluoromethyl, and thioalkoxy containing 1 to 3 carbon atoms; x is an integer of 1 to 3, with the proviso that R may be the same or different when x is 2 or 3; Rand Rcan be the same or different from each other and are independently selected from the group consisting of hydrogen, lower alkyl of 1 to 8 carbon atoms, aryl, arylalkyl, cycloalkyl of 3 to 7 carbon atoms; Rand Rcan be joined to form a 5 to 7-membered heterocycle substituted with a member selected from the group consisting of hydrogen, alkyl, and aryl groups, wherein the cyclic compound can comprise 1 to 2 nitrogen atoms and 0 to 1 oxygen atom, wherein the nitrogen atoms are not directly connected with each other or with the ox en atom.